A novel preparation method for 5-aminosalicylic acid loaded eudragit S100 nanoparticles

International Journal of Molecular Sciences

Volumn 13, Issue 5, 2012, Pages 6454-6468

  Hu, Daode ^a,b   Liu, Liang ^a   Chen, Wenjuan ^a   Li, Sining ^b   Zhao, Yaping ^b  

^a SHANGHAI FIRST PEOPLE S HOSPITAL   (China)

^b SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

5 ASA; Colon specific; Eudragit S100; Nanoparticles; Solution enhanced dispersion by supercritical fluids; Supercritical antisolvent

Indexed keywords

EUDRAGIT; MESALAZINE; NANOPARTICLE; ACRYLIC ACID RESIN; EUDRAGIT RS;

ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DIFFERENTIAL SCANNING CALORIMETRY; DRUG DEGRADATION; DRUG DETERMINATION; DRUG FORMULATION; DRUG RELEASE; FLOW RATE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INFRARED SPECTROSCOPY; PARTICLE SIZE; PH; PHYSICAL CHEMISTRY; PRESSURE MEASUREMENT; SUPERCRITICAL FLUID; TEMPERATURE SENSITIVITY; X RAY DIFFRACTION; CHEMISTRY; MEDICINAL CHEMISTRY; SURFACE PROPERTY; SYNTHESIS;

ACRYLIC RESINS; CHEMISTRY, PHARMACEUTICAL; MESALAMINE; NANOPARTICLES; PARTICLE SIZE; SURFACE PROPERTIES;

EID: 84861567127     PISSN: None     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms13056454     Document Type: Article

References (39)

1. Chourasia, M.K.; Jain, S.K. Pharmaceutical approaches to colon targeted drug delivery systems. J. Pharm. Pharm. Sci. 2003, 6, 33-66.
2. Kumar, P.; Mishra, B. Colon targeted drug delivery systems-an overview. Curr. Drug Deliv. 2008, 5, 186-198.
3. Pinto, J.F. Site-specific drug delivery systems within the gastro-intestinal tract: From the mouth to the colon. Int. J. Pharm. 2010, 16, 44-52.
4. Shah, N.; Shah, T.; Amin, A. Polysaccharides: A targeting strategy for colonic drug delivery. Expert Opin. Drug Deliv. 2011, 8, 779-796.
5. Williams, C.; Panaccione, R.; Ghosh, S.; Rioux, K. Optimizing clinical use of mesalazine (5-aminosalicylic acid) in inflammatory bowel disease. Ther. Adv. Gastroenterol. 2011, 4, 237-248.
6. Pertuit, D.; Moulari, B.; Betz, T.; Nadaradjane, A.; Neumann, D.; Ismaïli, L.; Refouvelet, B.; Pellequer, Y.; Lamprecht, A. 5-amino salicylic acid bound nanoparticles for the therapy of inflammatory bowel disease. J. Control. Release 2007, 123, 211-218.
7. Lamprecht, A.; Stallmach, A.; Kawashima, Y.; Lehr, C.M. Carrier systems for the treatment of inflammatory bowel disease. Drugs Future 2002, 27, 961-971.
8. Friend, D.R. New oral delivery systems for treatment of inflammatory bowel disease. Adv. Drug Deliv. Rev. 2005, 57, 247-265.
9. Lamprecht, A. Multiparticulate systems in the treatment of inflammatory bowel disease. Curr. Drug Targets Inflamm. Allergy 2003, 2, 137-144.
10. Lamprecht, A.; Yamamoto, H.; Takeuchi, H.; Kawashima, Y. Nanoparticles enhance therapeutic efficiency by selectively increased local drug dose in experimental colitis in rats. J. Pharmacol. Exp. Ther. 2005, 315, 196-202.
11. Lamprecht, A.; Schäfer, U.; Lehr, C.M. Size-dependent bioadhesion of micro-and nanoparticulate carriers to the inflamed colonic mucosa. Pharm. Res. 2001, 18, 788-793.
12. Lamprecht, A.; Ubrich, N.; Yamamoto, H.; Schäfer, U.; Takeuchi, H.; Maincent, P.; Kawashima, Y.; Lehr, C.M. Biodegradable nanoparticles for targeted drug delivery in treatment of inflammatory bowel disease. J. Pharmacol. Exp. Ther. 2001, 299, 775-781.
13. Moulari, B.; Pertuit, D.; Pellequer, Y.; Lamprecht, A. The targeting of surface modified silica nanoparticles to inflamed tissue in experimental colitis. Biomaterials 2008, 29, 4554-4560.
14. Kshirsagar, S.J.; Bhalekar, M.R.; Patel, J.N.; Mohapatra, S.K.; Shewale, N.S. Preparation and characterization of nanocapsules for colon-targeted drug delivery system. Pharm. Dev. Technol. 2011, doi:10.3109/10837450.2011.557732.
15. Nakase, H.; Okazaki, K.; Tabata, Y.; Uose, S.; Ohana, M.; Uchida, K.; Matsushima, Y.; Kawanami, C.; Oshima, C.; Ikada, Y.; Chiba, T. Development of an oral drug delivery system targeting immune-regulating cells in experimental inflammatory bowel disease: A new therapeutic strategy. J. Pharmacol. Exp. Ther. 2000, 292, 15-21.
16. Kalani, M.; Yunus, R. Application of supercritical antisolvent method in drug encapsulation: A review. Int. J. Nanomedicine 2011, 6, 1429-1442.
17. Mishima, K. Biodegradable particle formation for drug and gene delivery using supercritical fluid and dense gas. Adv. Drug Deliv. Rev. 2008, 60, 411-432.
18. Zu, Y.; Wang, D.; Zhao, X.; Jiang, R.; Zhang, Q.; Zhao, D.; Li, Y.; Zu, B.; Sun, Z. A novel preparation method for camptothecin (CPT) loaded folic acid conjugated dextran tumor-targeted nanoparticles. Int. J. Mol. Sci. 2011, 12, 4237-4249.
19. Zhao, X.; Zu, Y.; Jiang, R.; Wang, Y.; Li, Y.; Li, Q.; Zhao, D.; Zu, B.; Zhang, B.; Sun, Z. et al. Preparation and physicochemical properties of 10-hydroxycamptothecin (HCPT) nanoparticles by supercritical antisolvent (SAS) process. Int. J. Mol. Sci. 2011, 12, 2678-26591.
20. Kang, Y.; Yin, G.; Ouyang, P.; Huang, Z.; Yao, Y.; Liao, X.; Chen, A.; Pu, X. Preparation of PLLA/PLGA microparticles using solution enhanced dispersion by supercritical fluids (SEDS). J. Colloid Interface Sci. 2008, 322, 87-94.
21. Yeo, S.D.; Kim, M.S.; Lee, J.C. Recrystallization of sulfathiazole and chlorpropamide using the supercritical fluid antisolvent process. J. Supercrit. Fluids 2003, 25, 143-154.
22. Yeo, S.D.; Lee, J.C. Crystallization of sulfamethizole using the supercritical and liquid antisolvent processes. J. Supercrit. Fluids 2004, 30, 315-323.
23. Lee, B.M.; Jeong, J.S.; Lee, Y.H.; Lee, B.C.; Kim, H.S.; Kim, H.; Lee, Y.W. Supercritical antisolvent micronization of cyclotrimethylenetrinitramin: Influence of the organic solvent. Ind. Eng. Chem. Res. 2009, 48, 11162-11167.
24. Jin, H.Y.; Xia, F.; Zhao, Y.P. Preparation of hydroxypropyl methyl cellulose phthalate nanoparticles with mixed solvent using supercritical antisolvent process and its application in co-precipitation of insulin. Adv. Power Technol. 2012, 23, 157-163.
25. He, W.Z.; Suo, Q.L.; Hong, H.L.; Li, G.M.; Zhao, X.H.; Li, C.P.; Shan, A. Supercritical antisolvent micronization of natural carotene by the SEDS process through prefilming atomization. Ind. Eng. Chem. Res. 2006, 45, 2108-2115.
26. Hu, D.D.; Lin, C.C.; Liu, L.; Li, S.; Zhao, Y.P. Preparation, characterization, and in vitro release investigation of lutein/zein nanoparticles via solution enhanced dispersion by supercritical fluids. J. Food Eng. 2011, 109, 545-552.
27. Patomchaiviwat, V.; Paeratakul, O.; Kulvanich, P. Formation of inhalable rifampicin-poly (L-lactide) microparticles by supercritical anti-solvent process. AAPS PharmSciTech 2008, 9, 1119-1129.
28. Bleich, J.; Kleinebudde, P.; Müller, B.W. Influence of gas density and pressure on microparticles produced with the ASES process. Int. J. Pharm. 1994, 106, 77-84.
29. Xia, F.; Hu, D.D.; Jin, H.Y.; Zhao, Y.P.; Liang, J.M. Preparation of lutein proliposomes by supercritical anti-solvent technique. Food Hydrocoll. 2012, 26, 456-463.
30. Reverchon, E.; Antonacci, A. Polymer microparticles production by supercritical assisted atomization. J. Supercrit. Fluids 2007, 39, 444-452.
31. Reverchon, E.; Macro, I.D.; Porta, G.D. Tailoring of nano- and micro-particles of some superconductor precursors by supercritical antisolvent precipitation. J. Supercrit. Fluids 2002, 23, 81-87.
32. Franceschi, E.; de Cesaro, A.M.; Feiten, M.; Ferreira, S.R.S.; Dariva, C.; Kunita, M.H.; Rubira, A.F.; Muniz, E.C.; Corazza, M.L.; Oliveira, J.V. Precipitation of β-carotene and PHBV and co-precipitation from SEDS technique using supercritical CO2. J. Supercrit. Fluids 2008, 47, 259-269.
33. Wang, Y.; Wang, Y.; Yang, J.; Pfeffer, R.; Dave, R.; Michniak, B. The application of a supercritical antisolvent process for sustained drug delivery. Power Technol. 2006, 164, 94-102.
34. Franceschi, E.; de Cesaro, A.M.; Ferreira, S.R.S. Precipitation of β-carotene microparticles from SEDS technique using supercritical CO2. J. Food Eng. 2009, 95, 656-663.
35. Reverchon, E.; Della Porta, G.; Falivene, M.G. Process parameters and morphology in amoxicillin micro and submicro particles generation by supercritical antisolvent precipitation. J. Supercrit. Fluids 2000, 17, 239-248.
36. Bharate, S.S.; Bharate, S.B.; Bajaj, A.N. Interactions and incompatibilities of pharmaceutical excipients with active pharmaceutical ingredients: A comprehensive review. J. Excip. Food Chem. 2010, 1, 3-26.
37. Pignatello, R.; Ferro, M.; de Guidi, G.; Salemi, G.; Vandelli, M.A.; Guccione, S.; Geppi, M.; Forte, C.; Puglisi, G. Preparation, characterisation and photosensitivity studies of solid dispersions of diflunisal and Eudragit RS100 and RL100. Int. J. Pharm. 2001, 7, 27-42.
38. Maghsoodi, M.; Sadeghpoor, F. Preparation and evaluation of solid dispersions of piroxicam and Eudragit S100 by spherical crystallization technique. Drug Dev. Ind. Pharm. 2010, 36, 917-925.
39. Mladenovska, K.; Cruaud, O.; Richomme, P.; Belamie, E.; Raicki, R.S.; Venier-Julienne, M.C.; Popovski, E.; Benoit, J.P.; Goracinova, K. 5-ASA loaded chitosan-Ca-alginate microparticles: Preparation and physicochemical characterization. Int. J. Pharm. 2007, 345, 59-69.